Chromatics Color Sciences International. Inc; CCSI Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI

CCSI 29.32

+4.6%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mama Bear who wrote (4414)	8/13/1998 5:41:00 PM
From: Robin	Read Replies (2) of 5736

To all, FYI (assuming you care, diligent investors do) 2nd Qtr 98 Financial Results released for SPRX go2net.newsalert.com $389M in revenues for Q2. Assuming 50M revenues from other sources (no milestone payments that I am aware of this QTR) and an additional 50M for disposables, about 290M remains attributable to sales of Bilichek. At about $5M per, approximately 60 units sold internationally (Europe and Japan) in Q2. Company states initial manufacturing capacity exceeds current demand and expects situation to remain throughout 1998. Reports from the field indicate Bilichek is being well received (company hype, I admit). 510(k) for Bilichek to be filed with the FDA by the end of August. Respironics to begin sales of Bilichek in Canada in Q4. SPRX continues to move forward! Rockin' Robin

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next